Collagen is the main ECM constituent and we have previously shown that blocking the interaction of collagen with leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) results in tumour control in humanized mouse models [3, 4]. Here, LAIR1 is linked to neoplasm.